SCOTUS To Hear Case Challenging PTO Process For Overturning Patents

The U.S. Supreme Court agreed last week take up a case that will determine the constitutionality of the patent office’s inter partes review process -- an administrative procedure for challenging patents that some drug industry stakeholders have said undermines the drug pipeline and unfairly uses a lower standard for reviewing patents than that used by a district court. Despite ire over IPR in both the pharma sector and elsewhere, recent research from one law firm suggests that drug...